title: [Absence of clinical and biological manifestations after massive absorption of nitulamide].
abstract: Nitulamide (ANANDRON (R] is an antiandrogen used as an adjuvant therapy in the treatment of advanced prostatic cancer. The effects of ingestion of high doses of nitulamide has not been so far reported. A 79 years old man was admitted 2 hours after the ingestion of 13 g of nitulamide (170 mg/kg or 43 times the therapeutic dose), in a suicide attempt. He was receiving nitulamide 300 mg/day for two weeks. On admission, he underwent immediately gastric lavage, followed by administration of oral activated charcoal and received an intravenous infusion of glucose in balanced salt solution. During the first 12 hours, the patient presented with moderate vomiting and diarrhoea. There was no change in the following parameters: blood cell count, plasma electrolytes, serum transaminases and serum bilirubin, arterial blood gases, plasma cortisol value, as compared to the pre-treatment values. Chest X ray was unchanged. Plasma concentrations were measured 2 hours, 3 hours, 12 hours, 24 hours, 48 hours and 72 hours after ingestion. The initial level reached 6 times the normal therapeutic range, then fell to 3.5 times at the 72th hour. The patient recovered rapidly and was discharged on the 4th day. Biologic parameters were controlled on 4th, 9th, 30th day and remained unchanged. Treatment was started again on the 30th day with nitulamide 150 mg/day. We did not notice any side effect previously described in daily administration of nitulamide: anemia, rise in serum transaminases, interstitial pneumopathy.
authors: D
authors: D
authors: Rouger-Barbier
authors: D
authors: D
authors: Delefosse
authors: R
authors: R
authors: Pamphile
authors: G
authors: G
authors: Goldfarb
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000493:pharmacokinetics / Q000506:poisoning*; D006801:Humans; D007093:Imidazoles / Q000493:pharmacokinetics / Q000506:poisoning*; D048289:Imidazolidines; D008297:Male; D013405:Suicide
chemical_list: D000726:Androgen Antagonists; D007093:Imidazoles; D048289:Imidazolidines; C021277:nilutamide
vernacular_title: Absence de manifestation clinique et biologique après absorption massive de nitulamide.